Found: 25
Select item for more details and to access through your institution.
Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy?
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 307, doi. 10.1007/s10549-021-06331-3
- By:
- Publication type:
- Article
Increased gene expression variability in BRCA1-associated and basal-like breast tumours.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 363, doi. 10.1007/s10549-021-06328-y
- By:
- Publication type:
- Article
Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 399, doi. 10.1007/s10549-021-06315-3
- By:
- Publication type:
- Article
Medication use and mammographic breast density.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 585, doi. 10.1007/s10549-021-06321-5
- By:
- Publication type:
- Article
The impact of hyperbaric oxygen therapy on late radiation toxicity and quality of life in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 425, doi. 10.1007/s10549-021-06332-2
- By:
- Publication type:
- Article
Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 571, doi. 10.1007/s10549-021-06318-0
- By:
- Publication type:
- Article
The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the Netherlands.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 541, doi. 10.1007/s10549-021-06308-2
- By:
- Publication type:
- Article
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 411, doi. 10.1007/s10549-021-06329-x
- By:
- Publication type:
- Article
Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 333, doi. 10.1007/s10549-021-06316-2
- By:
- Publication type:
- Article
KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 347, doi. 10.1007/s10549-021-06325-1
- By:
- Publication type:
- Article
Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 387, doi. 10.1007/s10549-021-06314-4
- By:
- Publication type:
- Article
Variations in pathways and resource use in follow-up after abnormal mammography screening: a nationwide register-based study.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 551, doi. 10.1007/s10549-021-06312-6
- By:
- Publication type:
- Article
Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 561, doi. 10.1007/s10549-021-06317-1
- By:
- Publication type:
- Article
SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 317, doi. 10.1007/s10549-021-06298-1
- By:
- Publication type:
- Article
Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 521, doi. 10.1007/s10549-021-06304-6
- By:
- Publication type:
- Article
Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 509, doi. 10.1007/s10549-021-06303-7
- By:
- Publication type:
- Article
Psychological consequences of MRI-based screening among women with strong family histories of breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 497, doi. 10.1007/s10549-021-06300-w
- By:
- Publication type:
- Article
Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 533, doi. 10.1007/s10549-021-06305-5
- By:
- Publication type:
- Article
Prognostic factors for residual occult disease in shave margins during partial mastectomy.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 471, doi. 10.1007/s10549-021-06282-9
- By:
- Publication type:
- Article
New and persistent controlled substance use among patients undergoing mastectomy and reconstructive surgery.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 445, doi. 10.1007/s10549-021-06275-8
- By:
- Publication type:
- Article
Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 483, doi. 10.1007/s10549-021-06294-5
- By:
- Publication type:
- Article
Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 463, doi. 10.1007/s10549-021-06278-5
- By:
- Publication type:
- Article
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 455, doi. 10.1007/s10549-021-06276-7
- By:
- Publication type:
- Article
Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 377, doi. 10.1007/s10549-021-06143-5
- By:
- Publication type:
- Article
Pre-diagnostic DNA methylation patterns differ according to mammographic breast density amongst women who subsequently develop breast cancer: a case-only study in the EPIC-Florence cohort.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 435, doi. 10.1007/s10549-021-06273-w
- By:
- Publication type:
- Article